Inventor · disambiguated record
Jan Anderl
Also filed as: ANDERL JAN
6 granted patents·5 pending applications·28 citations·filing 2010–2023
79Inventor score
Files withMERCK PATENT GMBH3HEIDELBERG PHARMA GMBH2HEIDELBERG PHARMA RES GMBH2SIMON WERNER2ANDERL JAN1
Top patents by PatentIndex Score
11 records- 0186US10842882B2Amatoxin-antibody conjugatesHEIDELBERG PHARMA GMBH·Filed 2016·Granted Nov 24, 2020·5 cites·9 claims
- 0279US9399681B2Amatoxin-conjugates with improved linkersANDERL JAN·Filed 2011·Granted Jul 26, 2016·9 cites·16 claims
- 0379US9233173B2Amatoxin-armed therapeutic cell surface binding components designed for tumour therapyFAULSTICH HEINZ·Filed 2010·Granted Jan 12, 2016·11 cites·20 claims
- 0474US12201693B2Amanitin conjugatesHEIDELBERG PHARMA RES GMBH·Filed 2023·Granted Jan 21, 2025·0 cites·5 claims
- 0573US11590238B2Amanitin conjugatesHEIDELBERG PHARMA RES GMBH·Filed 2017·Granted Feb 28, 2023·1 cites·6 claims
- 0670US9982018B2Amatoxin derivativesHEIDELBERG PHARMA GMBH·Filed 2014·Granted May 29, 2018·2 cites·24 claims
- 0766US2025179210A1Anti-ceacam5 antibodies and conjugates and uses thereofMERCK PATENT GMBH·Filed 2023·Application pending·0 cites
- 0857US2025186603A1Anti-gd2 antibodies, immunoconjugates and therapeutic uses thereofMERCK PATENT GMBH·Filed 2023·Application pending·0 cites
- 0954US2018185509A1Amatoxin-conjugates with improved linkagesSIMON WERNER·Filed 2017·Application pending·0 cites
- 1054US2014294865A1Amatoxin-conjugates with improved linkagesSIMON WERNER·Filed 2012·Application pending·0 cites
- 1150US2025122282A2Anti-ceacam5 antibodies and conjugates and uses thereofMERCK PATENT GMBH·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jan Anderl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →